Core Scientific (NASDAQ:CORZ) Stock Price Target Cut by Needham & Company LLC

Core Scientific (NASDAQ:CORZ) had its target price reduced by investment analysts at Needham & Company LLC from $35.00 to $28.00 in a report released on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC‘s target price would indicate a potential upside of 138.10% from the stock’s current price.

A number of other research analysts have also weighed in on CORZ. Rothschild & Co Redburn began coverage on shares of Core Scientific in a research note on Monday, September 21st. They issued a “neutral” rating and a $16.00 price target on the stock. Capital One Financial set a $33.00 price objective on Core Scientific in a report on Thursday, July 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a research note on Thursday, October 15th. B. Riley Financial reduced their target price on Core Scientific from $42.00 to $31.00 and set a “buy” rating for the company in a report on Friday, October 30th. Finally, Compass Point reissued a “buy” rating and set a $36.00 target price on shares of Core Scientific in a report on Wednesday, July 29th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Core Scientific Stock Up 3.3%

CORZ opened at $11.76 on Friday. The company has a market cap of $3.78 billion, a price-to-earnings ratio of -3.37 and a beta of 5.56. Core Scientific has a 52-week low of $10.59 and a 52-week high of $30.46. The firm’s fifty day simple moving average is $15.68 and its two-hundred day simple moving average is $19.48.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Thursday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.54. The business had revenue of $232.87 million for the quarter, compared to analyst estimates of $196.54 million. Core Scientific had a negative net margin of 18.31% and a negative return on equity of 64.77%. On average, research analysts forecast that Core Scientific will post -1.36 EPS for the current year.

Insiders Place Their Bets

In other news, insider Todd DuChene sold 10,000 shares of the company’s stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $12.78, for a total transaction of $127,800.00. Following the completion of the sale, the insider owned 1,123,286 shares of the company’s stock, valued at $14,355,595.08. This represents a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Eric Weiss bought 6,000 shares of Core Scientific stock in a transaction dated Tuesday, September 15th. The stock was acquired at an average price of $16.33 per share, with a total value of $97,980.00. Following the completion of the transaction, the director directly owned 265,262 shares of the company’s stock, valued at approximately $4,331,728.46. The trade was a 2.31% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have bought 19,000 shares of company stock valued at $342,290 and have sold 100,000 shares valued at $1,628,600. 1.70% of the stock is owned by corporate insiders.

Institutional Trading of Core Scientific

Large investors have recently bought and sold shares of the business. Parallel Advisors LLC lifted its stake in Core Scientific by 125.0% in the 3rd quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock worth $29,000 after purchasing an additional 1,000 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Core Scientific by 1,371.3% in the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock valued at $30,000 after purchasing an additional 1,097 shares in the last quarter. CoreCap Advisors LLC purchased a new stake in shares of Core Scientific in the second quarter valued at approximately $36,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Core Scientific in the third quarter valued at approximately $42,000. Finally, Rakuten Securities Inc. acquired a new stake in shares of Core Scientific in the second quarter valued at approximately $47,000.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Core Scientific reported Q3 2026 earnings of $0.47 per share, versus analysts’ expected loss, while revenue of $232.87 million also exceeded estimates. The results provide a fundamental catalyst for investor optimism. Core Scientific surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Traders bought 143,273 CORZ call options Friday, about 127% above average volume. The surge may reflect increased bullish speculation, though options activity does not guarantee future gains.
• Neutral Sentiment: Needham cut its price target from $35 to $28 but maintained a Buy rating. The lower target tempers the outlook, while the continued Buy rating signals the analyst still sees substantial potential upside relative to the cited $11.76 price.
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for $127,800, reducing his holdings by 0.88%. The sale is a modest cautionary signal, although he retained more than 1.1 million shares. Core Scientific insider sale

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.